The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice

Immunotherapy has changed the therapeutic scenario of metastatic renal cell carcinoma (mRCC), however the evaluation of disease response to immune-checkpoint inhibitors is still an open challenge. Response evaluation criteria in solid tumors (RECIST) 1.1 criteria are the cornerstone of response asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Raimondi, Alessandra, Randon, Giovanni, Sepe, Pierangela, Claps, Melanie, Verzoni, Elena, de Braud, Filippo, Procopio, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747319/
https://www.ncbi.nlm.nih.gov/pubmed/31480348
http://dx.doi.org/10.3390/ijms20174263

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747319/
https://www.ncbi.nlm.nih.gov/pubmed/31480348
http://dx.doi.org/10.3390/ijms20174263

Ejemplares similares